Multiple Myeloma and Benign Monoclonal Gammopathy: Differentiation by Immunofluorescence of Lymphocytes
- FOLKE D. LINDSTRÖM, M.D.;
- WILLIAM R. HARDY, M.D.;
- BETTY J. EBERLE, Ph.D.; and
- RALPH C. WILLIAMS, JR., M.D.
Abstract
The proportions of T and B cells among peripheral blood lymphocytes were studied in 46 patients with plasma cell myeloma and in 14 patients with benign monoclonal gammopathy. Significant lowering (P < 0.001) of percentages of B cells having normal surface Ig was found in the myeloma group, whereas the patients with benign M-components showed normal proportions of B cells. Mean percentage of total B cells in myeloma patients was 10.3% ± 6.9%, whereas mean B-cell value in benign monoclonal gammopathy was 21.4% ± 11.7%. Normal B-cell values were 22.9% ± 7.1%. Myeloma patients in remission tended to have normal proportions of B cells. Individually specific or idiotypic M-component antigenic Ig markers were present in relatively high percentages in peripheral blood lymphocytes from two patients with myeloma, whereas the reverse was true in a patient with a benign M-component. There was some overlap in total B-cell values between patients with established myeloma and those with benign monoclonal gammopathy.
Article and Author Information
-
▸From the Department of Medicine, Bernalillo County Medical Center, University of New Mexico School of Medicine, Albuquerque, New Mexico.
-
Grant support: AM 13690-04 and AM 13824-04, U.S. Public Health Service; and a grant from the New Mexico Arthritis Foundation.
-
▸Requests for reprints should be addressed to Ralph C. Williams, Jr., M.D., 5th floor, Department of Medicine, Bernalillo County Medical Center, Albuquerque, NM 87106.
-
- Received January 2, 1973.
- Accepted March 15, 1973.
RSS Feeds









